PP213 Three-year follow-up of the ATTRACTION-4 Korean subgroup analysis: First-line (1L) nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with previously untreated, advanced, or recurrent gastric/gastro-esophageal junction (G/GEJ) cancer

Saved in:
Bibliographic Details
Published in:ESMO open 2023-12, Vol.8 (1), p.102169, Article 102169
Main Authors: Ryu, Min-Hee, Kang, Yoon-Koo, Oh, Do-Youn, Oh, Sang Cheul, Rha, Sun Young, Lee, Keun-Wook, Chung, Ik Joo, Oh, Sung Yong, Sym, Sun Jin, Kang, Won Ki, Kim, Jong Gwang, Shim, Byoung Yong, Kim, In-Ho, Kim, Jin Young, Song, Eun-Kee, Lee, Hyo-Jin, Kang, Seok Yun, Koo, Dong-Hoe, Oh, So Yeon
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2059-7029
2059-7029
DOI:10.1016/j.esmoop.2023.102169